August 17, 2022
Africa Aids and HIV Drugs Global development Global health news Society World news

Leading figures urge drugs firm to lower price of ‘game-changing’ HIV prevention drug

Signatories including Olly Alexander, Stephen Fry and Joseph Stiglitz issue a letter asking ViiV to make cabotegravir affordable to low- and middle-income countries

Nobel laureates, business leaders, former premiers and celebrities have urged a UK pharmaceutical company to lower the price of its groundbreaking HIV prevention drug and ensure it is not kept “out of reach” of the world’s poor.

In a letter signed by dozens of high-profile figures, including Sir Richard Branson, the singer Olly Alexander, the economist Joseph Stiglitz and Helen Clark, the former prime minister of New Zealand, the pharmaceutical company ViiV Healthcare is praised for having developed the first of a new kind of HIV prevention drug.

Continue reading…

Related posts

China accuses Australia of ‘violent’ interference in Five Eyes response to Hong Kong election


Tunisia referendum approves expansion of president’s powers – officials


China mulls bolstering laws on women’s rights and sexual harassment